Industries > Pharma > Global Vascular Grafts Market Report 2019-2029

Global Vascular Grafts Market Report 2019-2029

Analysis by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End-User (Hospital, Ambulatory Surgery Center), Company, Global Opportunity Analysis by Country and Industry Forecast

PAGES: 158
PRODUCT CODE: PHA0436
SUBMARKET: Medical Devices

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0436 Categories: , Tag:

Market Definition:
• Vascular grafts are medical devices used to bypass the infected or diseased blood vessels.
• Vascular grafts are required to replace injured blood vessels, veins, and arteries and to substitute hard blood vessels or valves.
• Vascular Grafts are mainly used in treatment of cardiovascular diseases by surgical procedures such as bypass grafting. The graft is taken from the patient’s body and surgically inserted at the required site to bypass the damaged or diseased blood vessels.

Market Overview and Trends
• Increasing incidence of cardiac diseases, diabetes, End Stage Renal Disease (ESRD), and vascular occlusions is the major factor responsible for market growth.
• Increase in geriatric population, technological advancements, and changes in life style (consumption of junk food, tobacco, and alcohol) are also expected to boost the market growth.
• Rising pervasiveness of cardiovascular diseases and aortic aneurysms coupled with chronic kidney disease will boost market growth during the foreseeable future.

Market Dynamics:

Factors Influencing the Market Growth:
• Rise in incidence of vascular disorders, high blood sugar, hypertension, and other risk factors that lead to blockage of blood vessels drive the growth of the vascular grafts market
• Sedentary lifestyle and unhealthy eating habits are also expected to boost the product demand over the forecast period.

Factors Restraining the Market Growth:
• Low reimbursement and high out-of-pocket expenditure in emerging economies may restrict the market growth to some extent.

Market Segmentation 2019-2029:
The Vascular Grafts market is segmented on the Indication, Raw Material, End User, and geography

1. Vascular Grafts Market, By Indication
a. EVAR
b. Abdominal
c. Thoracic

2. Vascular Grafts Market, By Raw Material
a. Polyester
b. ePTFE
c. Polyurethane
d. Biosynthetic

3. Vascular Grafts Market, By End User
a. Hospital
b. Ambulatory Surgery Center

4. Vascular Grafts Market, By Region
4.1 Introduction
4.2 North America
4.2.1 US
4.2.2 Canada
4.3 Europe
4.3.1 Germany
4.3.2 UK
4.3.3 France
4.3.4 Rest of Europe
4.4 Asia Pacific
4.4.1 Japan
4.4.2 China
4.4.3 India
4.4.4 Rest of Asia Pacific
4.5 Rest of the World (RoW)

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Vascular Grafts market.
• These companies has developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
• Medtronic, plc; LeMaitre Vascular Inc.; Terumo Corp.; Getinge AB; W.L. Gore and Associates, Inc.; and Cook Medical, Inc amongst others

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Vascular Grafts Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Vascular Grafts Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category